AQUATIC Trial

2 Year outcomes from the NOTION-2 trial

IPD Meta-Analysis of Contemporary Trials Comparing TAVI versus SAVR

Long-term Outcomes of the DanGer Shock Trial

TACSI: Dual or Single Antiplatelet Therapy After CABG in ACS Patients

DAPT-SHOCK-AMI Trial: Cangrelor in Cardiogenic Shock

TARGET-FIRST: Early Aspirin Discontinuation After PCI in Acute MI Patients

TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI

NEO-MINDSET: Early Withdrawal of Aspirin After PCI for ACS

DOUBLE-CHOICE: Anesthesia strategies and self-expanding valve types for TAVI

King and I | S6 E3 | Should EKG be the Discriminator for STEMI

The Impact of Gender on Outcomes of Transcatheter Aortic Valve Implantation Between Self-Expanding Valve and Balloon-Expandable Valve

Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction—Outcomes at two years

Is the axiom of balloon angioplasty, “the more you gain the more you lose,” still true in the era of DCB with paclitaxel?

Examining patient demographics and major adverse cardiac events following noncardiac surgery: Applying a health equity lens

Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A sub analysis of the EASTBOURNE study

Findings from EuroPCR 2025—What You Need to Know

EuroIntervention Highlights and Key Trial Recap from EuroPCR

King and I | S6 E2 | Welcome IC Fellows of 2025: Things You Need to Know

King and I | S5 E6 | Results and Implications of the ECLIPSE Study